Biosynex S.A.
ALBIO.PA
Get informed when a big investor buys or sells
+ FollowMarket Cap$15.67M
Close$
Share Statistics
| Market cap | $15.67 Million |
|---|---|
| Enterprise Value | $71.72 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-3.1 |
| Beta | 0.83 |
| Outstanding Shares | 18,750,000 |
Return
| Return on Equity | -312.86% |
|---|---|
| Return on Assets | -74.50% |
| Return on Invested Capital | -47.58% |
Valuation & Multiples
| P/E Ratio | -0.2 |
|---|---|
| PEG | 0.35 |
| Price to Sales | 0.08 |
| Price to Book Ratio | 0.78 |
| Enterprise Value to Revenue | 0.37 |
| Enterprise Value to EBIT | -1.4 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.9 |
| Debt to Equity | 1.99 |
Revenue Sources
No data
Insider Trades
Next Earnings Call
Expected Date
March 3, 2027
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Biosynex S.A.
397 employees
CEO: Larry Abensur Biosynex S.A. specializes in the development, manufacture, and worldwide distribution of rapid diagnostic solutions. Their extensive product line includes a variety of quick diagnostic assays, immunoblots, molecular biology tools, and po...